Incurable Neurodegenerative Disease

What We Know About Incurable Neurodegenerative Disease in the CUP Context

The “incurable neurodegenerative disease” category in the Texas CUP is a statutory umbrella covering several specific diagnoses — Parkinson’s disease, Huntington’s disease, certain motor neuron diseases, and others. Each diagnosis has its own clinical course and symptom profile; CUP evaluation considerations vary accordingly.

How TX CUP Addresses Neurodegenerative Disease

Low-THC products under the TX CUP for neurodegenerative-disease patients are evaluated in the context of symptom burden — typically including some combination of motor symptoms, sleep disruption, mood, and pain — rather than as disease-modifying therapy.

Our Experience Treating Neurodegenerative-Disease Patients Under CUP

Considerations CURT physicians evaluating these patients typically address:

• Coordination with the patient’s primary neurologist
• Specific diagnosis within the broader category
• Disease stage and current functional status
• Symptom-specific goals
• Drug-interaction screening against disease-specific therapies
• Caregiver context where advanced disease affects administration

What to Expect at the Evaluation

A CURT physician evaluating a neurodegenerative-disease patient typically reviews:

• Diagnostic workup confirming the specific neurodegenerative diagnosis
• Current treatment regimen
• Functional status assessment
• Symptom diary if maintained
• Caregiver context if applicable

Common Patient Questions About Neurodegenerative Disease and the TX CUP

Last Verified

Next Step

Bookings route through miracleleaftx.com.